Novo Nordisk NovoPen 6 Insulin Pen

NovoPen is a line of insulin delivery systems developed by Novo Nordisk, a global healthcare leader founded in Denmark. The brand originated from the merger of two small Danish companies, Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium, which were established in the 1920s to produce insulin.

Today, Novo Nordisk continues to be the ultimate owner and is headquartered in Bagsværd, Denmark. The company is largely controlled by the Novo Nordisk Foundation through its holding company, Novo Holdings A/S. While research and core manufacturing often take place in Denmark, the company has a massive global footprint with manufacturing facilities in countries like Brazil, China, France, and the USA to support the international demand for diabetes care products.